0.9% Sodium Chloride Injection, USP, 1000 mL, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-0300-10.
Published May 30, 2018 · Recall initiated: November 13, 2017
Summary
FDA records drug Class II recall D-0827-2018, published May 30, 2018 and initiated November 13, 2017. Recalling firm: Fresenius Medical Care Renal Therapies Group, LLC; Status: Terminated; Reported quantity: 25,356 1 liter bags; Lot: Lot # 17LU05005; Exp. 09/18 Part Number 060-10109. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fresenius Medical Care Renal Therapies Group, LLC
- Distributor
- Product was distributed throughout the United States.
- Lot
- Lot # 17LU05005; Exp. 09/18 Part Number 060-10109
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safeNovember 11, 2026
- FDADELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safeNovember 11, 2026
- FDADELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safeNovember 11, 2026
- FDADELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay"safeNovember 11, 2026
- FDADiclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, ManufacturedMay 30, 2018
- FDAPrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 10 mg, Rx Only, 48-count bottle, NDC 00378-4710-22May 30, 2018
Questions about this recall
Was 0.9% Sodium Chloride Injection, USP, 1000 mL, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-0300-10. recalled?
Yes. FDA published recall D-0827-2018 on May 30, 2018. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter